Covishield was developed by AstraZeneca and University of Oxford.
- It is the the Indian variant of AZD1222.
- 'Covishield is highly effective vaccine against novel coronavirus," said Adar Poonawalla, CEO, Serum Institute of India, which produces the vaccine in India.
No comments:
Post a Comment